Segmental haemangiomas of infancy: A review of 14 cases.
Haemangiomas of infancy are the commonest benign tumour in childhood, with the majority being a localized subtype, only requiring therapy in specific locations. The segmental subtype, however, confers a higher complication rate, an association with the PHACE syndrome and poorer prognosis. This retrospective case series of 14 infants with segmental haemangiomas aimed to further define the variety of clinical presentations, complication rates, and response to treatment in this subset of patients. We found in our series that 71% of infants with segmental haemangiomas develop at least one complication related to the lesion. Systemic corticosteroids prevented the further growth as well as reduced the pain and ulceration of the segmental haemangiomas in all of those treated. Early recognition and early treatment to arrest the growth of segmental haemangiomas will reduce morbidity and complications associated with these haemangiomas. Corticosteroid use, however, needs to be considered against the high incidence of side-effects such as secondary hypertension (40%), cushingoid features (40%) and growth suppression (67%). In our experience, these infants benefit from multidisciplinary team involvement for the assessment of associated syndromes, and to follow up and avoid complications associated with systemic therapy.
Phan
Tai Anh
TA
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Adams
Susan
S
Wargon
Orli
O
D000015:Abnormalities, Multiple / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D005260:Female; D006391:Hemangioma / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D008297:Male; D008499:Medical Records; D009517:New South Wales / Q000453:epidemiology; D010348:Patient Care Team; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D013577:Syndrome
D000305:Adrenal Cortex Hormones